Evaluation of Dentinal Fluid for the Presence of Matrix Metalloproteinase 9 (MMP-9) in Pulpal Inflammation
NCT ID: NCT02967081
Last Updated: 2018-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2016-10-31
2017-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments
NCT05145686
Pulp Inflammatory Markers and Outcome of Pulpotomy
NCT06960603
Hemostasis Achievement Reflecting Inflammatory Status of the Pulp Based on Cytokine Levels: A Cohort Study.
NCT03737682
A Comparative Evaluation of the Degree of Pain and MMP-9 Expression Following Instrumentation of Necrotic Pulps With Apical Periodontitis in One or Two Visits
NCT07101003
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy
NCT07261761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study is to use an improved sampling method for collection of MMP-9 to test the hypothesis that MMP-9 levels are significantly elevated in the dentinal fluid of symptomatic (painful) human permanent teeth compared to asymptomatic counterparts that need replacement of a filling, and pulp necrotic teeth. Moreover, the dynamics of MMP-9 expression after removal of the causative stimulus for pulpitis is to be investigated.
Outcome:
Measuring the total MMP-9 levels of dentinal fluid collected during dental treatment using a human MMP-9 fluorescent assay.
Measurements and procedures:
Patients attending the day service of the Center of Dental Medicine Zurich will be screened. Patients matching the inclusion criteria will be asked to participate in the study. Upon written informed consent, the affected tooth gets anesthetized, isolated with rubber dam and receives one of the following treatment procedures: caries removal and restoration, tooth filling replacement and restoration, or root canal treatment (because of irreversible pulpitis, or pulp necrosis). After caries removal, removal of the defect tooth filling, or during access cavity preparation, a cellulose membrane (paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid. The cellulose membrane will be stored until the laboratory analysis. Depending on the individual treatment plan of the patient, the tooth will subsequently receive root canal treatment, its final restoration, or a temporization with glass-ionomer cement for coverage of the dentinal wound and reinforcement of the remaining tooth structure. Final restoration of a tooth with composite, a partial crowns, or full-coverage crown can be technically demanding, time consuming, and frequently involves multiple patient visits. Teeth that receive root canal treatment, or the final restoration are sampled once. When a patient with a temporized tooth returns for the final restoration, the sampling procedure (appliance of a cellulose membrane to the dentin for 1 min and storage for further analyses) will be repeated. Any further treatment will be continued without further impairments. The investigation does not alter the treatment plan of any patient (either participating in one, or two sampling procedures, or in the study at all).
Number of participants:
Based on a previously performed study (Zehnder et al., 2011), which used a similar experimental set-up and had 31 participants (2 groups), it is aimed to recruit 60 participants for the current study.
Comparators:
MMP-9 levels in dentinal fluid sampled from teeth with painful (irreversible) pulpitis will be compared to MMP-9 levels of teeth without clinical signs and symptoms. Moreover, the MMP-9 levels of teeth showing an painless pulpitis (teeth affected by a caries lesion) will be compared to a repeated sample of the same tooth collected after removal of the caries lesion.
Statistical analysis:
MMP-9 contents in the clinical samples will be determined against a standard curve (4-parameter logistic curve fit) obtained from the recombinant pro-MMP-9 standard dilution series. Values between groups will be compared by using Mann-Whitney U test, with the alpha-type error set at 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulp necrosis
Collection of dentinal fluid using a cellulose membrane
After removal of the caries lesion/filling a cellulose membrane (sterile paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid.
Pulpitis (painless)
In this group the dentinal fluid will be sampled/collected twice: Firstly after the removal of the primary caries lesion. Subsequently the cavity will be temporized. Secondly, after removal of the temporary filling material (before final restoration).
Collection of dentinal fluid using a cellulose membrane
After removal of the caries lesion/filling a cellulose membrane (sterile paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid.
Irreversible pulpitis
Collection of dentinal fluid using a cellulose membrane
After removal of the caries lesion/filling a cellulose membrane (sterile paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid.
Normal pulp
Collection of dentinal fluid using a cellulose membrane
After removal of the caries lesion/filling a cellulose membrane (sterile paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collection of dentinal fluid using a cellulose membrane
After removal of the caries lesion/filling a cellulose membrane (sterile paper point) will be applied with its blunt end to the dentin for 1 min to collect dentinal fluid.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment of pain related to pulpal inflammation
* Caries therapy
* Root canal treatment of a pulp-necrotic tooth
* Replacement of an defect/fractured filling
Exclusion Criteria
* Patients who do not agree to participate in the study
* Patients with general diseases of inflammatory nature (such as diabetes, Crohn's disease, etc), or diseases affecting the immune-system (immuno-suppression, multiple morbidities, etc.)
* Women with known pregnancy
* Patients not fluent in German or English language
* Patients who had antibiotic or NSAID intake during the last 14 days
* Patients who refuse to be examined radiographically.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Zurich, Center of Dental Medicine
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zehnder M, Wegehaupt FJ, Attin T. A first study on the usefulness of matrix metalloproteinase 9 from dentinal fluid to indicate pulp inflammation. J Endod. 2011 Jan;37(1):17-20. doi: 10.1016/j.joen.2010.10.003.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PB_2016-02043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.